Patient Name : Ms. G.
DURGA KUMARI Sample ID : 22/10
Age/Sex : 40 Years/FEMALE Received On : 22-01-2026
Address : Report On : 22-01-2026
[Link] : SELF Sample Type : EDTA,SERUM
Sample Col. At : LAB Patient Id :
Investigation Result Units Biological [Link]
DEPARTMENT OF HAEMATOLOGY
Hemoglobin 9.4 gm% 11.5 - 16.0
(Method:SLS-Non cyanide)
Total RBC Count 3.13 [Link] 4.0 - 5.2
(Method:Impidence)
Total WB Count 12,200 Cells/[Link] 4000 - 11000
(Method:Impidence)
Differential Leucocyte Count
Neutrophils 50 % 40 - 70
Lymphocytes 40 % 20 - 40
Eosinophils 03 % 01 - 06
Monocytes 07 % 2 - 10
Hematocrit Value(Hct) 28.2 % 37 - 47
(Method:Electronic cellcytometry)
Mean Corpuscular Volume(MCV) 94 fl 83 - 101
(Method:Electronic cellcytometry)
Mean Cell Haemoglobin(MCH) 31 pg 27 - 32
Mean Cell Haemoglobin CON(MCHC) 32.98 % 32 - 36
Platelet Count 4.34 Cells/[Link] 1.5 - 4.0
(Method:Impidence)
Page 1 of 3
[Link] the Technician
.
Patient Name : Ms. [Link] KUMARI Sample ID : 22/10
Age/Sex : 40 Years/FEMALE Received On : 22-01-2026
Address : Report On : 22-01-2026
[Link] : SELF Sample Type : EDTA,SERUM
Sample Col. At: LAB Patient ID :
Investigation Result Units Biological [Link]
DEPARTMENT OF BIOCHEMISTRY
Fasting Blood Sugar 87 mg/dl 70 - 110
(Method:GOP/ POD)
LIPID PROFILE
Total Cholesterol 154 Desirable : <200
(Method:Cholesterol Oxidase / Esterase)
Borderline: 200 – 240
High Risk : >240
Triglycerides 139 mg/dl < 150
(Method:GPO - TOPS)
HDL Cholesterol 40 mg/dl 40 - 60
(Method:Direct Measurement)
LDL Cholesterol 86.2 mg/dl Desirable : < 130
(Method:Calculate Measurement)
Moderate Risk : 130 - 159
High Risk : > 160
VLDL Cholesterol 27.8 mg/dl Desirable : < 30
(Method:Calculated)
Total Cholesterol/HDL Cholesterol Ratio 3.85 0 - 4.5
(Method:Calculated)
Page 2 of 3
[Link] the Technician
.
Patient Name : Ms. [Link] KUMARI Sample ID : 22/10
Age/Sex : 40 Years/FEMALE Received On : 22-01-2026
Address : Report On : 22-01-2026
[Link] : SELF Sample Type : EDTA,SERUM
Sample Col. At: LAB Patient ID :
Investigation Result Units Biological [Link]
DEPARTMENT OF SEROLOGY
Widal Test (Slide Test)
WIDAL POSITIVE
Salmonella typhi "O" Antigen 1:160 DIL 1:80 & Above Significant
Salmonella typhi "H" Antigen 1:80 DIL 1:80 & Above Significant
Salmonella paratyphi "AH" Antigen NEGATIVE 1:80 & Above Significant
Salmonella paratyphi "BH" Antigen NEGATIVE 1:80 & Above Significant
(Method:NEGATIVE)
INTERPRETATION
Positive results obtained in the slide test should be confirmed with the tube test to establish whether the titers are diagnostically significant or not.
mAgglutinins usually appear by the end of the first week of infection, blood sample taken earlier may give a negative result. TAB vaccinated patients
may show a high titer of antibodies to each of the antigens. Similarly, an amnestic response to other vaccines and unrelated fever in case of patients
who have had prior infection or immunization may give false result. Generally antibody titers of 1:80 or more are considered clinically and diagnostically
significant. However the significant titer may vary from population to population and needs to be established for each area. It is recommended that
the results of the tests should be correlated with clinical findings to arrive at the finaldiagnosis.
C-Reactive Proteins(CRP) 5.4 Mg/L 0.0 - 6.0
(Method:Nephlometery)
INTERPRETATION
C - reactive protein (CRP) is an acute phase reactant protein that has the property of showing elevations in concentrations in response to stressful
or inflammatory states that occur with infection, injury, surgery, trauma or other tissue necrosis. Synthesis of CRP increases within 4-6 hours of on
set of inflammation, reaching peak values within 1-2 days. CRP levels also fall quickly after resolution of inflammation since its half life is 6 hours.
The main limitation of CRP is in its non specific response and should not be interpreted without a complete clinical history and evaluation
Page 3 of 3 *** End of the Report ***
.
[Link] the Technician